Stevanato Group S.p.A. (STVN) stock
STVNNYSESurgical & Medical Instruments & Apparatus
$15.36+0.11 (+0.72%)
Close on Nov 18, 2026Market cap $4.65BP/E 27.3Yield –
Stevanato Group S.p.A. operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was €198.80M, up 23.4% from the year before. The highest annual figure on record is €200.72M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €198.80M | +23.4% |
| FY2024 | Dec 31, 2024 | €161.14M | -19.7% |
| FY2023 | Dec 31, 2023 | €200.72M | +4.3% |
| FY2022 | Dec 31, 2022 | €192.43M | +18.6% |
| FY2021 | Dec 31, 2021 | €162.23M | +57.3% |
| FY2020 | Dec 31, 2020 | €103.11M | +65.7% |
| FY2019 | Dec 31, 2019 | €62.22M | – |
See a number that looks wrong?